Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Frishman

Showing results (161-170 of 1,858) with videos related to

Pageof 186
Sort By:
Cardiology in Review|February 2, 2023
The Use of Female Menopausal Hormonal Replacement Therapy To Prevent Cardiovascular Disease in Women and in Men: A Lack of Clinical Benefit and the Potential for HarmWilliam H Frishman
Scientific Reports|March 11, 2020
Edgetic perturbation signatures represent known and novel cancer biomarkersEvans Kataka, Jan Zaucha, Goar Frishman, et al.
Scientific Reports|February 6, 2021
Author Correction: Edgetic perturbation signatures represent known and novel cancer biomarkersEvans Kataka, Jan Zaucha, Goar Frishman, et al.
Cardiology in Review|February 3, 2025
Continuation Versus Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Undergoing Noncardiac SurgeryMohammed Kallash, William Frishman
Cardiology in Review|December 16, 2024
Right Ventricular Myocardial InfarctionsMohammed Kallash, William Frishman
Bioinformatics Advances|November 15, 2024
AAclust: <i>k</i>-optimized clustering for selecting redundancy-reduced sets of amino acid scalesStephan Breimann, Dmitrij Frishman
American Heart Journal|June 1, 1979
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsW Frishman, R Silverman
Bioinformatics (Oxford, England)|September 6, 2021
TCRpair: prediction of functional pairing between HLA-A*02:01-restricted T-cell receptor α and β chainsAnja Mösch, Dmitrij Frishman
BMC Bioinformatics|July 5, 2006
PROMPT: a protein mapping and comparison toolThorsten Schmidt, Dmitrij Frishman
Medicine and Health, Rhode Island|January 20, 1998
The history of assisted reproductive technology and its futureG Frishman, A Blazar
Pageof 186

Showing results (161-170 of 1,858) with videos related to

Sort By:
Pageof 186
Cardiology in Review|February 2, 2023
The Use of Female Menopausal Hormonal Replacement Therapy To Prevent Cardiovascular Disease in Women and in Men: A Lack of Clinical Benefit and the Potential for HarmWilliam H Frishman
Scientific Reports|March 11, 2020
Edgetic perturbation signatures represent known and novel cancer biomarkersEvans Kataka, Jan Zaucha, Goar Frishman, et al.
Scientific Reports|February 6, 2021
Author Correction: Edgetic perturbation signatures represent known and novel cancer biomarkersEvans Kataka, Jan Zaucha, Goar Frishman, et al.
Cardiology in Review|February 3, 2025
Continuation Versus Discontinuation of Angiotensin-Converting Enzyme Inhibitors and Angiotensin Receptor Blockers in Patients Undergoing Noncardiac SurgeryMohammed Kallash, William Frishman
Cardiology in Review|December 16, 2024
Right Ventricular Myocardial InfarctionsMohammed Kallash, William Frishman
Bioinformatics Advances|November 15, 2024
AAclust: <i>k</i>-optimized clustering for selecting redundancy-reduced sets of amino acid scalesStephan Breimann, Dmitrij Frishman
American Heart Journal|June 1, 1979
Clinical pharmacology of the new beta-adrenergic blocking drugs. Part 2. Physiologic and metabolic effectsW Frishman, R Silverman
Bioinformatics (Oxford, England)|September 6, 2021
TCRpair: prediction of functional pairing between HLA-A*02:01-restricted T-cell receptor α and β chainsAnja Mösch, Dmitrij Frishman
BMC Bioinformatics|July 5, 2006
PROMPT: a protein mapping and comparison toolThorsten Schmidt, Dmitrij Frishman
Medicine and Health, Rhode Island|January 20, 1998
The history of assisted reproductive technology and its futureG Frishman, A Blazar
Pageof 186